Philippe Lemey

Dr. Philippe Lemey

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Virus Evolution
Verified
Journal Article
Open access
PDF file
MSMarc A Suchard
Marc A Suchard
PLPhilippe Lemey
Philippe Lemey
GBGuy Baele
Guy Baele
DADaniel L Ayres
Daniel L Ayres
ADAlexei J Drummond
Alexei J Drummond
ARAndrew Rambaut
Andrew Rambaut
The Bayesian Evolutionary Analysis by Sampling Trees (BEAST) software package has become a primary tool for Bayesian phylogenetic and phylodynamic inference from genetic sequence data. BEAST unifies molecular phylogenetic reconstruction with complex discrete and continuous trait evolution, divergence-time dating, and coalescent demographic models in an efficient statistical inference engine using Markov chain Monte Carlo integration. A convenient, cross-platform, graphical user interface allows the flexible construction of complex evolutionary analyses.

21 May 2021 in Science
Verified
Journal Article
Open access
PDF file
NFNuno Rodrigues Faria
Nuno Rodrigues Faria
TMThomas A. Mellan
Thomas A. Mellan
CWCharles Whittaker
Charles Whittaker
ICIngra M. Claro
Ingra M. Claro
DCDarlan da S. Candido
Darlan da S. Candido
ESEster Cerdeira Sabino
Ester Cerdeira Sabino
Unmitigated spread in Brazil: Despite an extensive network of primary care availability, Brazil has suffered profoundly during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Using daily data from state health offices, Castro et al. analyzed the pattern of spread of COVID-19 cases and deaths in the country from February to October 2020. Clusters of deaths before cases became apparent indicated unmitigated spread. SARS-CoV-2 circulated undetected in Brazil for more than a month as it spread north from Sã o Paulo. In Manaus, transmission reached unprecedented levels after a momentary respite in mid-2020. Faria et al. tracked the evolution of a new, more aggressive lineage called P.1, which has 17 mutations, including three (K417T, E484K, and N501Y) in the spike protein. After a period of accelerated evolution, this variant emerged in Brazil during November 2020. Coupled with the emergence of P.1, disease spread was accelerated by stark local inequalities and political upheaval, which compromised a prompt federal response. Science , abh1558 and abh2644, this issue p. 821 and p. 815

28 July 2020 in Nature Microbiology
Verified
Journal Article
Closed access
PDF file
MBMaciej F. Boni
Maciej F. Boni
PLPhilippe Lemey
Philippe Lemey
XJXiaowei Jiang
Xiaowei Jiang
TLTommy Tsan-Yuk Lam
Tommy Tsan-Yuk Lam
BPBlair W. Perry
Blair W. Perry
DRDavid L. Robertson
David L. Robertson

4 September 2020 in Science
Verified
Journal Article
Open access
DCDarlan S. Candido
Darlan S. Candido
ICIngra M. Claro
Ingra M. Claro
JJJaqueline de Jesus
Jaqueline de Jesus
William SouzaWilliam Souza
William Souza
FMFilipe Moreira
Filipe Moreira
NFNuno Rodrigues Faria
Nuno Rodrigues Faria
The spread of SARS-CoV-2 in Brazil: Brazil has been hard-hit by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Candido et al. combined genomic and epidemiological analyses to investigate the impact of nonpharmaceutical interventions (NPIs) in the country. By setting up a network of genomic laboratories using harmonized protocols, the researchers found a 29% positive rate for SARS-CoV-2 among collected samples. More than 100 international introductions of SARS-CoV-2 into Brazil were identified, including three clades introduced from Europe that were already well established before the implementation of NPIs and travel bans. The virus spread from urban centers to the rest of the country, along with a 25% increase in the average distance traveled by air passengers before travel bans, despite an overall drop in short-haul travel. Unfortunately, the evidence confirms that current interventions remain insufficient to keep virus transmission under control in Brazil. Science , this issue p. 1255

26 August 2022 in Science
Verified
Journal Article
Open access
MWMichael Worobey
Michael Worobey
JLJoshua I. Levy
Joshua I. Levy
LSLorena Malpica Serrano
Lorena Malpica Serrano
ACAlexander Crits-Christoph
Alexander Crits-Christoph
JPJonathan E. Pekar
Jonathan E. Pekar
KAKristian G. Andersen
Kristian G. Andersen
Understanding how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in 2019 is critical to preventing future zoonotic outbreaks before they become the next pandemic. The Huanan Seafood Wholesale Market in Wuhan, China, was identified as a likely source of cases in early reports, but later this conclusion became controversial. We show here that the earliest known COVID-19 cases from December 2019, including those without reported direct links, were geographically centered on this market. We report that live SARS-CoV-2–susceptible mammals were sold at the market in late 2019 and that within the market, SARS-CoV-2–positive environmental samples were spatially associated with vendors selling live mammals. Although there is insufficient evidence to define upstream events, and exact circumstances remain obscure, our analyses indicate that the emergence of SARS-CoV-2 occurred through the live wildlife trade in China and show that the Huanan market was the epicenter of the COVID-19 pandemic.

1 July 2020 in Virus Evolution
Verified
Journal Article
Open access
SDSebastian Duchene
Sebastian Duchene
LFLeo Featherstone
Leo Featherstone
MHMelina Haritopoulou-Sinanidou
Melina Haritopoulou-Sinanidou
ARAndrew Rambaut
Andrew Rambaut
PLPhilippe Lemey
Philippe Lemey
GBGuy Baele
Guy Baele
The ongoing SARS-CoV-2 outbreak marks the first time that large amounts of genome sequence data have been generated and made publicly available in near real time. Early analyses of these data revealed low sequence variation, a finding that is consistent with a recently emerging outbreak, but which raises the question of whether such data are sufficiently informative for phylogenetic inferences of evolutionary rates and time scales. The phylodynamic threshold is a key concept that refers to the point in time at which sufficient molecular evolutionary change has accumulated in available genome samples to obtain robust phylodynamic estimates. For example, before the phylodynamic threshold is reached, genomic variation is so low that even large amounts of genome sequences may be insufficient to estimate the virus’s evolutionary rate and the time scale of an outbreak. We collected genome sequences of SARS-CoV-2 from public databases at eight different points in time and conducted a range of tests of temporal signal to determine if and when the phylodynamic threshold was reached, and the range of inferences that could be reliably drawn from these data. Our results indicate that by 2 February 2020, estimates of evolutionary rates and time scales had become possible. Analyses of subsequent data sets, that included between 47 and 122 genomes, converged at an evolutionary rate of about 1.1 × 10−3 subs/site/year and a time of origin of around late November 2019. Our study provides guidelines to assess the phylodynamic threshold and demonstrates that establishing this threshold constitutes a fundamental step for understanding the power and limitations of early data in outbreak genome surveillance.